News

NMPA GMP Standards: Key Updates and Impact on Foreign Pharma Manufacturers

NMPA · 11 min

NMPA Accelerated Approval Orphan Drugs: Impact & Future Trends in China

NMPA · rare diseases · 10 min

ICH Guidelines Biosimilar Development: Impact on APAC Approval Timelines

NMPA, PMDA, TGA, CDSCO, MFDS, HSA, TFDA · biosimilars · 10 min

Biosimilar Market Growth India: Key Drivers, Challenges & Opportunities

CDSCO · autoimmune · 10 min

Adalimumab Biosimilars Uptake: Australia vs Japan Market Analysis

TGA, PMDA · autoimmune diseases · 8 min

PMDA Biosimilar Framework: Impact on Trastuzumab Biosimilars in Japan

PMDA · Oncology · 9 min

NMPA Biosimilar Approval Pathway: What You Need to Know

NMPA · biosimilars · 10 min

Pompe Disease Treatments APAC: Market Growth and Regulatory Insights

NMPA, PMDA, TGA · Rare Diseases · 5 min

Bevacizumab Biosimilar Approval China: NMPA Greenlights First Biosimilar

NMPA · oncology · 4 min

Australia Leads APAC Early Phase Trials: TGA Pathways Analysis 2024

TGA · All · 5 min